US-based Convexity Scientific has announced the availability of its Flyp handheld ultrasonic nebulizer, which the company says received FDA clearance in May 2017. The Flyp nebulizer is lighter weight than a smartphone, the company said, with a rechargeable lithium-ion battery, and delivers most medications in about 7 minutes. Convexity is selling the Flyp nebulizer online for $249.
Convexity CEO Jim Daniels said, “Flyp is literally breathing new life into the nebulizer market by offering physicians a solution that puts convenience, portability and busy lifestyles at the forefront of how they treat patients with debilitating respiratory conditions, without compromising efficacy or patient outcomes.”
Convexity Co-Founder and Chairman Ralph Finger added, “For patients suffering from asthma, COPD and other lung-related diseases, Flyp offers a convenient and effective alternative to preventing and managing flare-ups. For years, the patient has been asked to fit their life to their nebulizer. Now with Flyp, there’s a nebulizer that fits into their life.”
Read the Convexity Scientific press release.
